Cargando…
Critical appraisal on mitochondrial dysfunction in Alzheimer’s disease
It is widely recognized that Alzheimer's disease (AD) is a common type of progressive neurodegenerative disorder that results in cognitive impairment over time. Approximately 152 million cases of AD are predicted to be reported by 2050. Amyloid plaques and tau proteins are two major hallmarks o...
Autores principales: | Ahmad, Faizan, Sachdeva, Punya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805294/ https://www.ncbi.nlm.nih.gov/pubmed/36606272 http://dx.doi.org/10.1002/agm2.12217 |
Ejemplares similares
-
Circadian dysfunction and Alzheimer's disease – An updated review
por: Ahmad, Faizan, et al.
Publicado: (2022) -
A consolidated review on stem cell therapy for treatment and management of Alzheimer's disease
por: Ahmad, Faizan, et al.
Publicado: (2022) -
Mitochondrial Dysfunction and Heart Disease: Critical Appraisal of an Overlooked Association
por: Bisaccia, Giandomenico, et al.
Publicado: (2021) -
Ketamine as a therapeutic agent in major depressive disorder and posttraumatic stress disorder: Potential medicinal and deleterious effects
por: Sachdeva, Bhuvi, et al.
Publicado: (2023) -
Potential natural products for the management of autism spectrum disorder
por: Sachdeva, Punya, et al.
Publicado: (2022)